Literature DB >> 1466766

Guanine-nucleotide binding activity, interaction with GTPase-activating protein and solution conformation of the human c-Ha-Ras protein catalytic domain are retained upon deletion of C-terminal 18 amino acid residues.

J Fujita-Yoshigaki1, Y Ito, K Yamasaki, Y Muto, T Miyazawa, S Nishimura, S Yokoyama.   

Abstract

A truncated human c-Ha-Ras protein that lacks the C-terminal 18 amino acid residues and the truncated Ras protein with the amino acid substitution Gly-->Val in position 12 were prepared by an E. coli overexpression system. The truncated Ras protein showed the same guanine-nucleotide binding activity and GTPase activity as those of the full-length Ras protein. Further, the same extent of GTPase activity enhancement due to GTPase-activating protein was observed for the truncated and full-length Ras proteins. In fact, two-dimensional proton NMR analyses indicated that the tertiary structure of the truncated Ras protein (GDP-bound or GMPPNP-bound) was nearly the same as that of the corresponding catalytic domain of the full-length Ras protein. Moreover, a conformational change around the effector region upon GDP-->GMPPNP exchange occurred in the same manner for both proteins. These observations indicate that the C-terminal flanking region (18 amino acid residues) of the Ras protein does not appreciably interact with the catalytic domain. Therefore, the truncated Ras protein is suitable for studying the molecular mechanism involved in the GTPase activity and the interaction with the GTPase-activating protein. On the other hand, an active form of the truncated Ras protein, unlike that of the full-length Ras protein, did not induce neurite outgrowth of rat pheochromocytoma PC12 cells. Thus, membrane anchoring of the Ras protein through its C-terminal four residues is not required for the interaction of Ras and GAP, but may be essential for the following binding of the Ras-GAP complex with the putative downstream target.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466766     DOI: 10.1007/bf01024974

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  35 in total

1.  Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins.

Authors:  M V Milburn; L Tong; A M deVos; A Brünger; Z Yamaizumi; S Nishimura; S H Kim
Journal:  Science       Date:  1990-02-23       Impact factor: 47.728

2.  Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21.

Authors:  A M de Vos; L Tong; M V Milburn; P M Matias; J Jancarik; S Noguchi; S Nishimura; K Miura; E Ohtsuka; S H Kim
Journal:  Science       Date:  1988-02-19       Impact factor: 47.728

3.  Spin-labeling proton NMR study on aromatic amino acid residues in the guanine nucleotide binding site of human c-Ha-ras(1-171) protein.

Authors:  A Hata-Tanaka; G Kawai; K Yamasaki; Y Ito; H Kajiura; J M Ha; T Miyazawa; S Yokoyama; S Nishimura
Journal:  Biochemistry       Date:  1989-11-28       Impact factor: 3.162

4.  Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line.

Authors:  M Noda; M Ko; A Ogura; D G Liu; T Amano; T Takano; Y Ikawa
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

5.  The p21 ras C-terminus is required for transformation and membrane association.

Authors:  B M Willumsen; A Christensen; N L Hubbert; A G Papageorge; D R Lowy
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

6.  Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus.

Authors:  T Y Shih; M O Weeks; P Gruss; R Dhar; S Oroszlan; E M Scolnick
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

7.  Proton NMR studies of the GDP.Mg2+ complex of the Ha-ras oncogene product p21.

Authors:  I Schlichting; A Wittinghofer; P Rösch
Journal:  Biochem Biophys Res Commun       Date:  1988-01-15       Impact factor: 3.575

8.  Conformation of guanosine 5'-diphosphate as bound to a human c-Ha-ras mutant protein: a nuclear Overhauser effect study.

Authors:  J M Ha; Y Ito; G Kawai; T Miyazawa; K Miura; E Ohtsuka; S Noguchi; S Nishimura; S Yokoyama
Journal:  Biochemistry       Date:  1989-10-17       Impact factor: 3.162

9.  Transforming activity of human tumor DNAs.

Authors:  T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

10.  Human-tumor-derived cell lines contain common and different transforming genes.

Authors:  M Perucho; M Goldfarb; K Shimizu; C Lama; J Fogh; M Wigler
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

View more
  3 in total

1.  Cell-free synthesis and amino acid-selective stable isotope labeling of proteins for NMR analysis.

Authors:  T Kigawa; Y Muto; S Yokoyama
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

2.  Sequence-specific 1H and 15N resonance assignments and secondary structure of GDP-bound human c-Ha-Ras protein in solution.

Authors:  Y Muto; K Yamasaki; Y Ito; S Yajima; H Masaki; T Uozumi; M Wälchli; S Nishimura; T Miyazawa; S Yokoyama
Journal:  J Biomol NMR       Date:  1993-03       Impact factor: 2.835

3.  Photocontrol of the GTPase activity of the small G protein K-Ras by using an azobenzene derivative.

Authors:  Seigo Iwata; Shinsaku Maruta
Journal:  Biochem Biophys Rep       Date:  2015-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.